|OAD||Office of the Associate Director
Plans, evaluates and coordinates extramural clinical research programs testing combined modality approaches and the testing of investigational new agents.
|IDB||Investigational Drug Branch
Implements and oversees an innovative investigational experimental therapeutics program. IDB collaborates with academia and industry through a unique contract and grant NCI funded program to carry out the clinical evaluation of novel anti-cancer agents.
|CGCB||Clinical Grants and Contracts Branch
The CGCB is the point-of-contact for the extramural community engaged in investigator-initiated clinical research.
|PMB||Pharmaceutical Management Branch
Provides pharmaceutical support for clinical trials sponsored by CTEP. Collects and maintains registration documentation for all investigators participating in CTEP clinical trials.
|CIB||Clinical Investigations Branch
Responsible for scientific oversight and coordination of large, multicenter clinical trials exploring innovative disease therapeutics and biomarkers; partners with public and private entities to expand clinical trial participation to all populations.
|CTOIB||Clinical Trials Operations and Informatics Branch
Provides support of protocol development and conduct through the Protocol and Information Office, the CTEP Enterprise System, the NCI Central Institutional Review Board, the Cancer Trials Support Unit and various process evaluation tools.
|CTMB||Clinical Trials Monitoring Branch
Audits clinical data and deters scientific misconduct by ensuring good clinical practices. Having the highest quality data along with protecting rights of human subjects are major goals.
|RAB||Regulatory Affairs Branch
The Regulatory Affairs Branch (RAB) provides IND support and acts as liaison to the FDA for CTEP, DCTD. RAB also fosters pharmaceutical collaboration in evaluating new anti-cancer agents, through the implementation of appropriate agreements.
|ARC||Administrative Resource Center
Provides outstanding administrative services, in a customer friendly environment, to support the progress of cancer research. The ARC values are integrity, respect, perseverance, trust and reliability.
CTEP is responsible, within DCTD, for coordinating the largest, publicly funded oncology clinical trials organization in the world. With over 900 active trials enrolling annually 30,000 study participants, More...
CTEP Scientific Meetings
Newsletters / Reports